|
|
|
MIRA INFORM REPORT
|
Report No. : |
502130 |
|
Report Date : |
11.04.2018 |
IDENTIFICATION DETAILS
|
Name : |
BAROQUE PHARMACEUTICALS PRIVATE LIMITED |
|
|
|
|
Registered Office
: |
D-403, 4th Floor, Titanium Square, S.G. Highway, Thaltej, Ahmedabad – 380054, Gujarat |
|
Tel. No.: |
91-2698-302502/03/04 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
23.11.1993 |
|
|
|
|
Com. Reg. No.: |
04-020695 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 9.163 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230GJ1993PTC020695 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
0897004850 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACB6277H |
|
|
|
|
CST No.: |
24650700615 |
|
|
|
|
TIN No.: |
24150700615 |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
24AAACB6277H1ZQ |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Pharmaceuticals Drugs. [Confirmed by Management] |
|
|
|
|
No. of Employees
: |
235 (Approximately) |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Maximum Credit Limit : |
USD 626900 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company incorporated in the year 1993 and it is having good track. For the financial year 2017, the company has increased in its revenue from operations as compared to previous year and maintained decent profitability margin of 11.59%. Rating takes into consideration sound financial profile of the company marked by healthy networth base and low debt balance sheet. Further, rating also derives strength from its established track record of business operations and decent improvement in the revenue as well as profitability profile during the year. However, rating strengths are partially offset by intensely competitive nature of industry and working capital intensive operations. Trade relations are reported as fair. Business is active. Payment terms are seems to be regular. In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term Rating = BBB |
|
Rating Explanation |
Moderate degree of safety and moderate credit risk |
|
Date |
12.12.2017 |
|
Rating Agency Name |
CRISIL |
|
Rating |
Short Term Rating = A3 |
|
Rating Explanation |
Moderate degree of safety and higher credit risk |
|
Date |
12.12.2017 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 11.04.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION PARTED BY [GENERAL DETAILS]
|
Name : |
Mr. Alpesh Patel |
|
Designation : |
Accounts Manager |
|
Contact No.: |
91-7574878021 |
|
Date : |
09.04.2018 |
LOCATIONS
|
Registered/ Corporate Office : |
D-403, 4TH Floor, Titanium Square, S.G. Highway, Thaltej, Ahmedabad – 380054, Gujarat, India |
|
Tel. No.: |
91-79-40009421 |
|
Mobile No.: |
91-7574878021 [Mr. Alpesh Patel] |
|
Fax No.: |
91-79-40009422 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
Locality : |
Industrial |
|
|
|
|
Manufacturing Site and Office Address : |
192/2 and 3, At Sokhada, Taluka Khambhat, District Anand-388620, Gujarat, India |
|
Tel. No.: |
91-2698-226286/302502/302503/ 04 |
|
Fax No.: |
91-2698-302504 |
|
E-Mail : |
DIRECTORS
AS ON: 31.03.2017
|
Name : |
Mr. Pragnesh Jayantibhai Patel |
|||||||||||||
|
Designation : |
Director |
|||||||||||||
|
Address : |
97, Nityanand Society, Ambakhan Road, Khambhat, Anand – 388620,
Gujarat, India |
|||||||||||||
|
Date of Birth/Age : |
02.08.1984 |
|||||||||||||
|
Date of Appointment : |
01.05.2003 |
|||||||||||||
|
DIN No.: |
00336790 |
|||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
|
Name : |
Mr. Jayantibhai Dhulabhai Patel |
|||||||||||||
|
Designation : |
Managing Director |
|||||||||||||
|
Address : |
97, Nityanand Society, Ambakhan Road, Khambhat, Anand – 388620,
Gujarat, India |
|||||||||||||
|
Date of Birth/Age : |
15.07.1955 |
|||||||||||||
|
Date of Appointment : |
01.04.1996 |
|||||||||||||
|
DIN No.: |
00336835 |
|||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
|
Name : |
Dr. Jignesh Mayurbhai Patel |
|||||||||||||
|
Designation : |
Wholetime Director |
|||||||||||||
|
Address : |
Shivam Hospital, Khambhat, Anand – 388620, Gujarat, India |
|||||||||||||
|
Date of Birth/Age : |
26.04.1976 |
|||||||||||||
|
Date of Appointment : |
01.04.2008 |
|||||||||||||
|
DIN No.: |
02194627 |
|||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
|
Name : |
Mr. Lalit Rameshchandra Saraswat |
|||||||||||||
|
Designation : |
Director |
|||||||||||||
|
Address : |
Baroque Pharmaceuticals Private Limited. Taluka Khambhat, Sokhada -388620, Gujarat, India |
|||||||||||||
|
Date of Birth/Age : |
25.11.1969 |
|||||||||||||
|
Date of Appointment
: |
01.05.2011 |
|||||||||||||
|
DIN No.: |
03562155 |
|||||||||||||
|
||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. Alpesh Patel |
|
Designation : |
Accounts Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON: 31.03.2017
|
Names of Shareholders |
|
No. of Shares |
|
Jayantibhai Dhulabhai Patel |
|
29906 |
|
Manjulabhai Jayantibhai Patel |
|
5489 |
|
Pragnesh Jayantibhai Patel |
|
16766 |
|
Jayantibhai D Patel & Manjulabhai J Patel |
|
2040 |
|
Amita Jayantibhai Patel |
|
2841 |
|
Lalit R. Saraswat |
|
394 |
|
Jigneshbhai Mayurbhai Patel |
|
530 |
|
Jayantibhai Dhulabhai Patel HUF |
|
13834 |
|
Replica Remedies Private Limited |
|
19825 |
|
|
|
|
|
Total |
|
91625 |
AS ON: 29.09.2017
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Promoters – Individual/ Hindu Undivided Family – Indian |
78.36 |
|
Promoters – Body Corporate |
21.64 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Drugs. [Confirmed by Management] |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
|
||||
|
Products : |
Pharmaceuticals Drugs |
||||
|
Countries : |
· South Africa · Latin America · Philippines · Cambodia |
||||
|
|
|
||||
|
Imports : |
Not Available |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Credit [60 Days] |
||||
|
|
|
||||
|
Purchasing : |
Credit [100 Days] |
PRODUCTION STATUS: NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
· Anand Jyot Printpack · Aarex Pharma · Aaseem Packaging · Alen Pharma · Amin Traders · Anand Enterprises |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Customers : |
Wholesalers · Asia Business Services Private Limited · Base Pharmaceutical Private Limited · SRK Enterprise · Clex Medicals Pte. Limited, Singapore |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
No. of Employees : |
235 (Approximately) |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Bankers : |
· HDFC Bank Limited |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Auditors : |
|
|
Name : |
B C Patel and Company Chartered Accountants |
|
Address : |
Desai Building, Mayfair Road, Anand – 388001, Gujarat, India |
|
Mobile No.: |
91-9714732300 |
|
PAN No.: |
AENPP3444E |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associate Company : |
Replica Remedies Private Limited (U24230GJ1998PTC034955) |
|
|
|
|
Subsidiary Company : |
Baroque Therapeutics Private Limited (U33112GJ2016PTC093831) |
CAPITAL STRUCTURE
AS ON: 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
500000 |
Equity Shares |
INR 100/- each |
INR 50.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
91625 |
Equity Shares |
INR 100/- each |
INR 9.163
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
9.163 |
9.163 |
4.625 |
|
(b) Reserves & Surplus |
210.252 |
154.909 |
74.291 |
|
(c) Money received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application
money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
219.415 |
164.072 |
78.916 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
134.063 |
83.550 |
27.063 |
|
(b) Deferred tax liabilities (Net) |
6.061 |
3.749 |
1.593 |
|
(c)
Other long term liabilities |
0.000 |
0.000 |
23.000 |
|
(d)
long-term provisions |
0.000 |
0.000 |
0.000 |
|
Total
Non-current Liabilities (3) |
140.124 |
87.299 |
51.656 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a)
Short term borrowings |
61.273 |
5.031 |
41.937 |
|
(b)
Trade payables |
0.000 |
0.000 |
0.000 |
|
(c)
Other current liabilities |
195.766 |
135.284 |
82.402 |
|
(d)
Short-term provisions |
10.574 |
9.682 |
6.396 |
|
Total
Current Liabilities (4) |
267.613 |
149.997 |
130.735 |
|
|
|
|
|
|
TOTAL |
627.152 |
401.368 |
261.307 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a)
Fixed Assets |
|
|
|
|
(i)
Tangible assets |
155.455 |
150.000 |
121.968 |
|
(ii)
Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii)
Capital work-in-progress |
132.516 |
43.690 |
28.871 |
|
(iv) Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current
Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets
(net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan
and Advances |
5.105 |
0.005 |
0.005 |
|
(e)
Other Non-current assets |
6.334 |
2.728 |
0.090 |
|
Total
Non-Current Assets |
299.410 |
196.423 |
150.934 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
27.412 |
26.299 |
12.187 |
|
(c)
Trade receivables |
229.420 |
153.840 |
81.030 |
|
(d)
Cash and cash equivalents |
0.909 |
4.294 |
4.826 |
|
(e)
Short-term loans and advances |
49.166 |
16.906 |
8.511 |
|
(f)
Other current assets |
20.835 |
3.606 |
3.819 |
|
Total
Current Assets |
327.742 |
204.945 |
110.373 |
|
|
|
|
|
|
TOTAL |
627.152 |
401.368 |
261.307 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue from Operations |
505.997 |
416.920 |
256.656 |
|
|
|
Other Income |
28.370 |
19.826 |
7.614 |
|
|
|
TOTAL |
534.367 |
436.746 |
264.270 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
295.492 |
261.481 |
157.789 |
|
|
|
Purchases of Stock-in-Trade |
20.808 |
21.625 |
13.400 |
|
|
|
Changes in Inventories |
3.604 |
(5.419) |
0.039 |
|
|
|
Employees benefits expense |
51.700 |
34.142 |
24.113 |
|
|
|
Other expenses |
58.388 |
45.020 |
30.894 |
|
|
|
TOTAL |
429.992 |
356.849 |
226.235 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
104.375 |
79.897 |
38.035 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
8.155 |
9.550 |
4.925 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
96.220 |
70.347 |
33.110 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/ AMORTISATION |
9.856 |
9.190 |
7.625 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
86.364 |
61.157 |
25.485 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
27.713 |
21.376 |
8.952 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
58.651 |
39.781 |
16.533 |
|
|
|
|
|
|
|
|
|
|
Earnings/ (Loss)
Per Share (INR) |
640.12 |
434.18 |
357.48 |
|
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Cash generated from operations |
NA |
NA |
NA |
|
|
|
|
|
|
Net Cash flow from (used in) Operations |
NA |
NA |
NA |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
165.49 |
134.68 |
115.24 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
2.21 |
2.71 |
3.17 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
3.81 |
3.04 |
3.12 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.36 |
0.41 |
0.25 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.64 |
0.58 |
0.60 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.89 |
0.54 |
0.87 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
1.22 |
0.91 |
1.66 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
1.31 |
1.18 |
1.91 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
12.80 |
8.37 |
7.72 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
11.59 |
9.54 |
6.44 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
9.35 |
9.91 |
6.33 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
26.73 |
24.25 |
20.95 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.22 |
1.37 |
0.84 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
1.12 |
1.19 |
0.75 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.35 |
0.41 |
0.30 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
21.32 |
9.67 |
14.92 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.22 |
1.37 |
0.84 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
4.625 |
9.163 |
9.163 |
|
Reserves & Surplus |
74.291 |
154.909 |
210.252 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
78.916 |
164.072 |
219.415 |
|
|
|
|
|
|
long-term borrowings |
27.063 |
83.550 |
134.063 |
|
Short term borrowings |
41.937 |
5.031 |
61.273 |
|
Current Maturities of Long
term debt |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
69.000 |
88.581 |
195.336 |
|
Debt/Equity
ratio |
0.874 |
0.540 |
0.890 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
256.656 |
416.920 |
505.997 |
|
|
|
62.443 |
21.365 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
256.656 |
416.920 |
505.997 |
|
Profit/ (Loss) |
16.533 |
39.781 |
58.651 |
|
|
6.44% |
9.54% |
11.59% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
Yes |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
Yes |
|
19 |
Major customers |
Yes |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES
|
CHARGES REGISTERED |
||||||||
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
G37389061 |
100081011 |
HDFC BANK LIMITED |
01/10/2016 |
- |
- |
1200000.0 |
HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WESTMUMBAIMH400013IN |
|
2 |
G79356812 |
100018201 |
STATE BANK OF INDIA |
18/03/2016 |
16/02/2018 |
- |
322000000.0 |
SPECIALISED COMMERCIAL BRANCH, JAY LAXMI PLAZA,GANESH CIRCLE, ANANDANANDGJ388001IN |
|
3 |
G79352829 |
100018219 |
STATE BANK OF INDIA |
18/03/2016 |
16/02/2018 |
- |
322000000.0 |
SPECIALISED COMMERCIAL BRANCH, JAY LAXMI PLAZA,GANESH CIRCLE, ANANDANANDGJ388001IN |
|
4 |
C53894010 |
10569906 |
STATE BANK OF INDIA |
09/03/2015 |
- |
- |
4500000.0 |
STATION ROAD BRANCHKHAMBHATGJ388620IN |
|
5 |
C52591849 |
10567345 |
STATE BANK OF INDIA |
20/12/2014 |
- |
- |
40000000.0 |
STATION ROAD BRANCH, STATION ROAD,KHAMBHAT, TAL. KHAMBHAT, DIST. ANAND, GUJARATAHMEDABADGJ388620IN |
|
6 |
A84012251 |
10215339 |
BANK OF BARODA |
29/03/2010 |
- |
- |
20000000.0 |
CAMBAY INDUSTRIAL ESTATE BRANCHKANSARIGJ388630IN |
|
7 |
A21061171 |
10063884 |
BANK OF BARODA |
30/07/2007 |
- |
- |
850000.0 |
JAWAHAR ROAD, CAMBAY BRANCHANANDGJ388620IN |
|
8 |
Y10192380 |
90102688 |
BANK OF BARODA |
22/03/2001 |
- |
- |
7760000.0 |
COMBAY BRANCHANANDGJIN |
|
9 |
Y10188992 |
90099300 |
BANK OF BARODA |
03/01/2001 |
- |
- |
7760000.0 |
COMBAY BRANCHANANDGJIN |
|
10 |
Y10192312 |
90102620 |
BANK OF BARODA |
30/01/1997 |
04/12/1998 |
- |
1250000.0 |
COMBAY BRANCHANANDGJIN |
UNSECURED LOANS
|
PARTICULARS |
31.03.2017 (INR
In Million) |
31.03.2016 (INR
In Million) |
|
LONG-TERM BORROWINGS |
|
|
|
Loans and Advances From Related Parties |
23.747 |
23.371 |
|
|
|
|
|
Total |
23.747 |
23.371 |
CHANGE OF ADDRESS:
The Registered address of the company has been shifted from At- Sokhada,
Khambhat Tal: Khambhat, Dist: Anand-388620, Gujarat, India to the present
address w.e.f 18.10.2013
FIXED ASSETS:
· Air Condition
· Air Cooler
· Boiler
· CCTV
· Computers
· Fax Machine
· Furniture and Dead Stock
· Lab Equipments
· Land
· Plant and Machinery
·
Water cooler
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 64.94 |
|
UK Pound |
1 |
INR 91.75 |
|
Euro |
1 |
INR 79.90 |
INFORMATION DETAILS
|
Information
Gathered by : |
PNM |
|
|
|
|
Analysis Done by
: |
PRS |
|
|
|
|
Report Prepared
by : |
RUP |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.